Back
13
Day Range
$1.36
$1.36
52-Week Range
$1.24
$1.85
Volume
100
50D / 200D Avg
$1.52
/
$1.45
Prev Close
$1.42
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.4 | 10.4 |
| P/B | 0.1 | 1.2 |
| ROE % | 22.1 | 12.6 |
| Net Margin % | 2.9 | 5.3 |
| Rev Growth 5Y % | 15.1 | 5.5 |
| D/E | 4.3 | 0.6 |
Key Takeaways
Revenue grew 15.05% annually over 5 years — strong growth
ROE of 22.11% indicates high profitability
Debt/Equity of 4.34 — high leverage
Generating 38.60B in free cash flow
P/E of 0.43 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 11.83%
Growth
Revenue Growth (5Y)
15.05%
Revenue (1Y)3.22%
Earnings (1Y)11.19%
FCF Growth (3Y)-19.00%
Quality
Return on Equity
22.11%
ROIC2.39%
Net Margin2.85%
Op. Margin2.20%
Safety
Debt / Equity
4.34
Current Ratio0.61
Interest Coverage1.47
Valuation
P/E Ratio
0.43
P/B Ratio0.09
EV/EBITDA23.60
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.22% | Revenue Growth (3Y) | 5.15% |
| Earnings Growth (1Y) | 11.19% | Earnings Growth (3Y) | 23.49% |
| Revenue Growth (5Y) | 15.05% | Earnings Growth (5Y) | 21.38% |
| Profitability | |||
| Revenue (TTM) | 989.85B | Net Income (TTM) | 28.18B |
| ROE | 22.11% | ROA | 2.87% |
| Gross Margin | 22.72% | Operating Margin | 2.20% |
| Net Margin | 2.85% | Free Cash Flow (TTM) | 38.60B |
| ROIC | 2.39% | FCF Growth (3Y) | -19.00% |
| Safety | |||
| Debt / Equity | 4.34 | Current Ratio | 0.61 |
| Interest Coverage | 1.47 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 0.43 | P/B Ratio | 0.09 |
| P/S Ratio | 0.01 | PEG Ratio | 1.31 |
| EV/EBITDA | 23.60 | Dividend Yield | 0.03% |
| Market Cap | 12.12B | Enterprise Value | 515.00B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 989.85B | 959.00B | 895.28B | 829.10B | 565.06B |
| Net Income | 28.18B | 25.35B | 18.48B | 13.27B | 12.99B |
| EPS (Diluted) | 3.10 | 2.77 | 2.01 | 1.39 | 1.33 |
| Gross Profit | 224.93B | 216.51B | 196.27B | 178.00B | 120.29B |
| Operating Income | 21.82B | 50.72B | 42.27B | 36.08B | 18.73B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 982.01B | 944.12B | 926.49B | 924.06B | 931.89B |
| Total Liabilities | 660.68B | 624.51B | 624.90B | 633.76B | 639.09B |
| Shareholders' Equity | 128.08B | 126.86B | 111.00B | 100.72B | 104.13B |
| Total Debt | 556.05B | 424.59B | 427.53B | 446.88B | 462.28B |
| Cash & Equivalents | 53.16B | 54.61B | 67.23B | 71.42B | 92.35B |
| Current Assets | 152.43B | 137.15B | 143.80B | 148.96B | 165.77B |
| Current Liabilities | 250.37B | 232.38B | 238.20B | 207.44B | 214.89B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#505 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026